Identification of the Major Serum Albumin Adduct Formed by 4-Aminobiphenyl in Vivo in Rats

PL Skipper, MW Obiedzinski, SR Tannenbaum… - Cancer research, 1985 - AACR
PL Skipper, MW Obiedzinski, SR Tannenbaum, DW Miller, RK Mitchum, FF Kadlubar
Cancer research, 1985AACR
Serum albumin was isolated from rats at 27 h after administration of the carcinogen [2, 2′-
3H]-4-aminobiphenyl. Pronase digestion of the purified albumin yielded a mixture of
radiolabeled materials which was resolved into 5 major components by reverse-phase liquid
chromatography. From detailed UV, 1H-NMR, and mass spectral analyses, four of these
were determined to be 4-aminobiphenyl, 4′-hydroxy-4-acetylaminobiphenyl, and two other
metabolites, all of which are presumed to be non-covalently associated with the serum …
Abstract
Serum albumin was isolated from rats at 27 h after administration of the carcinogen [2,2′-3H]-4-aminobiphenyl. Pronase digestion of the purified albumin yielded a mixture of radiolabeled materials which was resolved into 5 major components by reverse-phase liquid chromatography. From detailed UV, 1H-NMR, and mass spectral analyses, four of these were determined to be 4-aminobiphenyl, 4′-hydroxy-4-acetylaminobiphenyl, and two other metabolites, all of which are presumed to be non-covalently associated with the serum albumin. The fifth component, however, resulted from covalent bond formation and was identified as a tetrapeptide containing 3-tryptophanyl-4-acetylaminobiphenyl, the amino acid sequence of which was H2N-ala-trp-alaval. Since rat serum albumin contains only a single tryptophan residue in a hydrophobic drug binding site, its high selectivity for carcinogen binding suggests a unique role for this protein in the detoxification and/or transport of ultimate carcinogenic metabolites.
AACR